Application Nr Approved Date Route Status External Links
ANDA208258 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tazarotene Cream, 0.1% Is Indicated As An Adjunctive Agent For Use In The Mitigation (Palliation) Of Facial Fine Wrinkling, Facial Mottled Hyper-And Hypopigmentation, And Benign Facial Lentigines In Patients Who Use Comprehensive Skin Care And Sunlight Avoidance Programs. Tazarotene Cream, 0.1% Is A Retinoid Indicated As An Adjunctive Agent For Use In The Mitigation (Palliation) Of Facial Fine Wrinkling, Facial Mottled Hyper- And Hypopigmentation, And Benign Facial Lentigines In Patients Who Use Comprehensive Skin Care And Sunlight Avoidance Programs. ( 1 ) Limitations Of Use: Does Not Eliminate Or Prevent Wrinkles Or Restore More Youthful Skin. ( 1 ) Does Not Repair Sun Damaged Skin Or Reverse Photoaging. ( 1 ) Safety And Effectiveness For The Prevention Or Treatment Of Actinic Keratoses, Skin Neoplasms, Or Lentigo Maligna Have Not Been Established. ( 1 , 5.4 ) Limitations Of Use: Tazarotene Cream Does Not Eliminate Or Prevent Wrinkles Or Restore More Youthful Skin. Tazarotene Cream Does Not Reverse Photoaging Or Repair Sun Damaged Skin; Tazarotene Cream Does Not Mitigate Coarse Or Deep Wrinkling, Tactile Roughness, Telangiectasia, Skin Laxity, Keratinocytic Atypia, Melanocytic Atypia, Or Dermal Elastosis. The Safety And The Effectiveness Of Tazarotene Cream For The Prevention Or Treatment Of Actinic Keratoses, Skin Neoplasms, Or Lentigo Maligna Have Not Been Established.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tazarotene TAZAROTENE ZINC1542199

Comments